SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius ($CELH) is trending as investors anticipate upcoming earnings, with some expecting a strong report due to the Alani Nu acquisition and increased distribution with Pepsi. Community members are actively discussing potential price targets and whether the stock will break out, while also noting pre-earnings manipulation. Bullish sentiment seems high, with many believing $CELH is poised for continued growth in the energy drink market.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending following Q3 earnings and a new $400M AI partnership with Perplexity. Community discussions revolve around the potential for a short squeeze and the long-term implications of AI integration for Snap's growth and profitability, with some expressing skepticism about the company's ability to sustain its gains.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo ($DUOL) is trending as investors debate the impact of AI on its business model after a recent price drop; discussions revolve around whether AI translation tools pose a significant threat to the language learning app's user base and revenue growth. Community members are analyzing the company's growth metrics, subscription numbers, and expansion into new areas like chess amid differing views on its long-term prospects. Some traders are also watching for a potential bounce, citing oversold conditions and strong underlying fundamentals.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health's stock is trending amidst mixed sentiment, with some traders citing positive earnings reports and potential ACA extensions as catalysts for a surge, while others express concern about revenue misses and the impact of subsidy changes; the community is actively debating its near-term trajectory and long-term growth potential within the evolving healthcare landscape, with many focused on potential breakout points.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending amidst mixed sentiment after its recent earnings report, with the community debating whether growth is truly accelerating as guided. Bulls point to undervaluation compared to peers like LMND, while bears cite concerns about profitability and sustainability. Discussion also revolves around potential short squeezes and upcoming catalysts.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending due to a recent sales forecast that disappointed investors, leading to a stock drop and a Piper Sandler downgrade; however, the retail sector remains optimistic. Community discussions revolve around the company's growth potential, tariff impacts, and whether the sell-off is an overreaction. Some traders are eyeing potential bounce plays, while others express concerns about profitability and consumer spending.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending amid speculation around potential partnerships and analyst upgrades, with Oppenheimer setting a price target of $115. Community discussions revolve around the possibility of a tie-up with OpenAI and the stock's potential to reach new all-time highs, while some traders are wary of resistance levels and recent downgrades.

SuperCom Ltd. engages in the provision of traditional and digital identity solutions. It offers identification, tracking, and security products to government, private and public organization. It operates through the following divisions: e-Gov, Internet of Things (IoT), and Cyber Security. The e-Gov division provides solutions for traditional and biometrics enrollment, personalization, issuance and border control services. The IoT division products and services reliably identify, track, and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles, and monitored objects. The Cyber Security division is involved in the comprehensive solutions to protect the organization's sensitive data residing on servers, laptops, and detachable devices. The company was founded by Jack Hasan and Eli Rozen on July 4, 1988 and is headquartered in Tel Aviv, Israel.

SuperCom Ltd

SPCB is trending as investors anticipate upcoming earnings and potential catalysts, including new contracts and expansion in the electronic monitoring sector. Community discussions revolve around the company's growth prospects, recurring revenue model, and potential for an ICE contract, which some believe could significantly drive up the stock price. Bullish sentiment is fueled by recent contract wins and expectations for continued momentum.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as analysts raise price targets following strong Q3 revenue growth driven by its gaming business and early e-commerce platform success. The community is bullish, anticipating further gains and focusing on the potential of the AI-driven Axon platform, with some eyeing a retest of all-time highs, though there are concerns about valuation and regulatory scrutiny.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in October 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Shares of Fortinet are trending sharply lower, driven by concerns over forward guidance despite a Q3 earnings beat, sparking debates about the company's growth trajectory and market position. The community is actively discussing whether the dip represents a buying opportunity or signals deeper challenges amidst mixed analyst ratings and reports of legal uncertainty. Discussions include the impact of competition and the potential of AI and cloud services to drive future growth for the cybersecurity firm.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of +6.25% and +0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Danaher (DHR) Q2 Earnings and Revenues Top Estimates

Danaher (DHR) delivered earnings and revenue surprises of +9.76% and +1.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners, Inc. (SGRY) on Tuesday announced that it has <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.surgerypartners.com/news-releases/news-release-details/surgery-partners-inc-and-bain-capital-conclude-discussions">decided</a> to reject Bain Capital Private Equity’s proposal to take the healthcare services company private. Following the announcement, SGRY stock slumped 13% by Tuesday morning.Surgery Partners, headquartered in Brentwood, Tennessee, said that the firm’s independent committee determined that the company’s prospects to deliver long-term growth and value creation as an independent publicly traded company exceeded the value of the proposal by Bain Capital, its largest shareholder. &nbsp;Brent Turner, Chairman of the independent committee, said that it believes the best path forward for Surgery Partners is to continue operating as an independent publicly traded company.“We remain confident in the management team’s ability to continue delivering sustained growth and significant stockholder returns,” he said.Bain Capital put forth its proposal to acquire all of the outstanding shares of Surgery Partners not already owned by it for a cash consideration of $25.75 per share in January.Meanwhile, CEO Eric Evans on Tuesday also expressed confidence in the company achieving its full-year 2025 revenue and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance.The company expects to report 2025 revenues in the range of $3.30 billion to $3.45 billion and adjusted EBITDA in the range of $555 million to $565 million for the year.Bain Capital Partners Andrew Kaplan and Devin O’Reilly also said that they remain “tremendously optimistic” about the business despite not being able to agree on the terms of the transaction.<a href="https://stocktwits.com/symbol/SGRY">SGRY stock</a> is down 6% this year and approximately 20% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-agrees-to-acquire-verve-therapeutics-for-up-to-1.3-billion/chlYyFpRRTy">Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal

Chairman of the Independent Committee, Brent Turner, said the best path forward for Surgery Partners is to continue operating as an independent publicly traded company.

Equity

9 Analysts Assess Surgery Partners: What You Need To Know

Latest Ratings for SGRY
 DateFirmActionFromTo Mar 2022JP MorganMaintainsNeutral Mar 2022SVB LeerinkMaintainsOutperform Mar 2022RBC CapitalMaintainsOutperform
 View More Analyst Ratings for SGRY...

What 8 Analyst Ratings Have To Say About Surgery Partners

Surgery Partners (SGRY) Poised for Upside: A Comprehensive Buy Rating Justification

In a report released on July 18, Whit Mayo from Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY Research Report), with a price...

Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know

While shareholders of Surgery Partners (NASDAQ:SGRY) are in the black over 5 years, those who bought a week ago aren't so fortunate

Surgery Partners, Inc. ( NASDAQ:SGRY ) shareholders might be concerned after seeing the share price drop 13% in the...

Surgery Partners: A Buy Rating Amidst Underperformance and Growth Potential

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY Research Report), retaining the price target of $47.00. W...

Surgery Partners (SGRY, $29.94) Stochastic Oscillator left the overbought zone on March 27, 2024

This is a signal that SGRY's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Current Price	$21.96
Prev Close	$22.00
Open	$22.02
Dividend Yield	0.00%
50-Day Moving Average	$21.67
Beta	1.40
Avg. Volume	1.18M
PE Ratio	-15.37

52-Week High	$31.89
52-Week Low	$18.87
Market Capitalization	$2.82B
EPS (Annual)	-$1.33
Price to Book	1.61
Revenue Per Employee	$207,620.00
Enterprise Value/EBITDA	N/A

SGRY
Surgery Partners Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SGRY News

SGRYSurgery Partners Inc